文献速递前列腺增生与排尿功能障碍前列腺癌

前列腺光选择性汽化术治疗主动监测前列腺癌患者的下尿路症状

Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.
PubMed 文献 · Urology · 2021-02-02

术后12个月IPSS、最大尿流率、残余尿、PSA及前列腺体积均显著改善,3年仍处于主动监测的概率为93%(95%CI 87%-100%),未对疾病进展率产生不良影响。

要点

  • 光选择性汽化术可显著缓解主动监测前列腺癌患者的难治性下尿路症状。
  • 术后12个月PSA下降36%,3年仍保持主动监测的概率为93%(95%CI 87%-100%)。
  • 术后30天仅2例III级并发症,晚期组织再生长4例、尿道狭窄3例。

核心结论

  • 前列腺光选择性汽化术能大幅缓解主动监测患者难治性症状,且不增加疾病进展风险。

主要发现

  • 术后12个月平均IPSS从18降至5.9,最大尿流率从6.8升至14 mL/s,残余尿从240降至73 mL。
  • 术后12个月平均PSA从8.1降至5.2 ng/mL,前列腺体积从85降至57 mL,PSA下降36%。
  • 术后30天仅2例III级并发症;晚期组织再生长4例,尿道狭窄需单次扩张3例。
  • 中位随访3.7年,7例进展并接受根治性治疗,3年仍主动监测概率93%(95%CI 87%-100%)。

临床怎么用

  • 对主动监测中因难治性下尿路症状需手术的前列腺癌患者,可考虑光选择性汽化术缓解症状。
  • 术后需监测组织再生长和尿道狭窄等晚期并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To demonstrate the safety and efficacy of photoselective vaporization of the prostate in alleviating refractory lower urinary tract symptoms in prostate cancer patients who are managed with active surveillance and to explore the association of this procedure with prostate specific antigen (PSA) levels and cancer progression rates. METHODS: Between 2008-2018, active surveillance patients who had refractory symptoms and needed surgery were studied. Perioperative functional variables were collected and analyzed. Disease progression was defined as an upgrade or upstage on surveillance biopsies or multiparametric prostate magnetic resonance imaging. Mean postop scores were estimated using locally-weighted methods. The risk of progression was reported using Kaplan-Meier's method. RESULTS: Seventy-one patients were included in the study. The median age was 68 years and the median surveillance time before surgery was 4 years. At 12 months, there were substantial improvements in the mean International Prostate Symptom Score (18-5.9), maximum flow rate (6.8-14 mL/s), postvoid residual (240-73mL), PSA (8.1-5.2 ng/mL), and prostate volume (85-57mL). At 30-days, only 2 patients with grade-III complications. Late consequences included tissue regrowth in 4 and urethral stricture (requiring a single dilation) in 3 patients. PSA levels decreased by 36% at 12 months postoperatively. With a median follow-up of 3.7 years, 7 men progressed and received radical treatment. At 3 years, the probability of remaining on surveillance was 93% (95% CI 87%- 100%). CONCLUSION: Photoselective vaporization of the prostate offers substantial relief of symptoms in active surveillance patients with refractory symptoms, without adverse effects on disease progression rates.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Jibara G, Sjoberg DD, Stearns GL, et al. Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance. Urology. 2021. PMID: 33539897. doi:10.1016/j.urology.2021.01.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。